Guo, Xuejiao
Li, Lin
Yan, Zhe
Li, Yunze
Peng, Zhiyou
Yang, Yixin
Zhang, Yanfeng
Schmitz, Christoph
Feng, Zhiying http://orcid.org/0000-0003-0962-9449
Article History
Received: 17 September 2021
Accepted: 15 November 2021
First Online: 4 December 2021
Declarations
:
: This study was approved by the Ethics Committee of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China (no. 2017-515, dated 27/07/2017) and was carried out in accordance with the World Medical Association Declaration of Helsinki. The study was registered with ClinicalTrials.gov (Identifier NCT03337607). We have obtained consent for publication from all patients.
: This study was performed with the radial extracorporeal shock wave device Swiss DolorClast, which was invented and is manufactured and distributed by Electro Medical Systems (Nyon, Switzerland). CS has received research funding at LMU Munich and consulted (until December 31st, 2017) for Electro Medical Systems. However, Electro Medical Systems had no role in InternalRef removed, data collection, data analysis, data interpretation, or writing of the report. All other authors declare no competing interests.